Prashant Yadav (@prof-yadav.bsky.social)
@Prof_Yadav_SCM
Better health & economic development through better supply chains, globally. #globalhealth; #supplychain. Views are entirely mine.
Pfizer/BioNTech's COVID-19 vaccine results are an encouraging development. Many more steps before ready to ship (e.g. establish manufacturing consistency). Logistics readiness is also much ⬆️ than before. My views @SquawkCNBC this morning. cc @TinglongDai cnbc.com/video/2020/11/…
Read @Prof_Yadav_SCM, Chloe Searchinger, and @TomBollyky on “the national security challenge of overdependence on foreign sources for critical medicines”—and how the United States can fortify its pharmaceutical supply chain: foreignaffairs.com/united-states/…
Deeply shocked and saddened by the passing of our dear friend, colleague and @WHO Envoy David Nabarro. David was a great champion of global health and health equity, and a wise, generous mentor to countless individuals. His work touched and impacted so many lives across the…
The United States’ growing dependence on foreign drugs puts national security at risk—but imposing high tariffs on essential generic medicines will not make the country safer, argue @Prof_Yadav_SCM and @TomBollyky. foreignaffairs.com/united-states/…
.@Prof_Yadav_SCM and @TomBollyky discuss the United States’ growing dependence on foreign sources for critical medicines—and call on policymakers to diversify the U.S. pharmaceutical supply chain: foreignaffairs.com/united-states/…
A blanket tariff on pharmaceuticals would indeed hike costs by 10% and risk shortages, as the U.S. imports 80% of its generics. This isn't just a policy misstep—it's a direct threat to American families' health and wallets.
“A blanket tariff on pharmaceutical imports would only worsen the dangers posed by the United States’ growing dependence on foreign drugs and drug inputs,” argue @Prof_Yadav_SCM and @TomBollyky. foreignaffairs.com/united-states/…
According to @TomBollyky Chloe Searchinger and @Prof_Yadav_SCM Blanket pharma tariffs would WORSEN America's dangerous drug dependency problem, not solve It. They would lead to shortages of life-saving meds like chemo drugs, penicillin & injectable medicines. Why? These have…
Procuring pandemic countermeasures demands new capabilities, innovative contracting approaches, & a greater tolerance for risk. Demand is highly volatile and unpredictable; some manufacturers are new or untested; incentives to maintain production capacity are weak; and often,…
On 11 July 2025, @ADB_HQ will host a Symposium on Multilateral Financing for Pandemic Preparedness and Response in Manila. The symposium features a session on procurement for medical countermeasures. You can also join us via Zoom: lnkd.in/ei7zKtX6.
Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation - The Lancet Global Health thelancet.com/journals/langl…
The US needs to address the lack of supply resilience for critical generic medicines. But the global generic companies rightly point out that investment in US domestic manufacturing is too risky in such a low-margin business. It needs other tools of industrial policy (hint: not…
.@US_FDA steps up to stop new trials exporting sending American citizens’ living cells for genetic engineering, often without informed consent. Safeguards on patient privacy and data integrity are indeed extremely important in this respect. #Biosecurity #ClinicalTrials…
I had the opportunity to participate in the G20 Health Working Group meeting in Johannesburg from June 10–12. The sessions on medical countermeasures and pandemic preparedness were quite insightful. I spoke at the G20 Strategic Dialogue on Advancing Equitable Access to NCD…
Novo Nordisk's patent maintenance fees lapse/non payment in Canada. By Derek Lowe @ScienceMagazine science.org/content/blog-p…
Un hommage mérité, Monsieur le Président. Le Dr Amadou Sall a incarné une vision audacieuse de souveraineté scientifique et pharmaceutique pour l’Afrique. Le vaccinopôle de Diamniadio en est un symbole fort. Plein succès au Dr Ibrahima Soce Fall. L’IPD reste un pilier…
Je rends hommage au Dr Amadou Sall, Administrateur sortant de l’Institut Pasteur de Dakar, pour son action à la tête de cet établissement et son immense contribution au processus de souveraineté pharmaceutique du Sénégal à travers notamment le pilotage de la mise en place du…
🌍Global health supply chain is coming to Rwanda! Rwanda Medical Supply Ltd (RMS) is thrilled and deeply honored to co-host the Global Health Supply Chain Summit 2025, in Kigali this November! We will welcome global health leaders who will share bold and innovative ideas for…
Shocking news: Bi Jingquan, former CFDA head, is under investigation for alleged serious disciplinary and legal violations. A surprising fall for the pharmaceutical reform titan who drove significant regulatory reforms that cleared drug approval backlogs, enhanced generic drug…
Amid #WHA78, the @WorldHealthSmt session on “Taking Responsibility for Health in a Fragmented World” sparked some key reflections for me. Grateful to @IlonaKickbusch for incisive and thoughtful questions on trade, industrial policy, & global health. Hope it sparks a continued…
Ministers from multiple countries hit by the abrupt cuts in external funding for health agreed on the urgent need for country-owned and implemented strategies – and a laser-sharp focus on health data who.int/news/item/21-0…